Zobrazeno 1 - 10 of 40 pro vyhledávání: '"Rischke HC"'
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
[Radiological-nuclear medicine hybrid diagnostics with SPECT/CT for chronic foot and ankle diseases : A new and important diagnostic tool].
Autor: Rischke HC; SPECT/CT-Institut Freiburg, Schwabentorplatz 6, 79098, Freiburg, Deutschland. rischke@nuklearmedizin-freiburg.de., Hase C; Fuß- und Sprunggelenkchirurgie, Loretto-Krankenhaus Freiburg, Freiburg, Deutschland., Schneider T; Sportmedizin, Fuß- und Sprunggelenkchirurgie, Gelenkklinik Gundelfingen, Gundelfingen, Deutschland., Walther M; Zentrum für Fuß- und Sprunggelenkchirurgie, Schön Klinik München-Harlaching, München, Deutschland.
Publikováno v: Orthopadie (Heidelberg, Germany) [Orthopadie (Heidelb)] 2023 Jun; Vol. 52 (6), pp. 495-503. Date of Electronic Publication: 2023 Apr 27.
Zobrazit plný text záznamu
7
Akademický článek
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial.
Autor: Gkika E; Department of Radiation Oncology, Medical Center, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine, University of Freiburg, Germany. Electronic address: eleni.gkika@uniklinik-freiburg.de., Schimek-Jasch T; Department of Radiation Oncology, Medical Center, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kremp S; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Lenz S; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Germany., Stockinger M; Department of Radiation Oncology, University Hospital Mainz, Germany., Schaefer-Schuler A; Department of Nuclear Medicine, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Mix M; Faculty of Medicine, University of Freiburg, Germany; Department of Nuclear Medicine, Medical Center, University of Freiburg, Germany., Küsters A; Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany., Tosch M; Department of Nuclear Medicine, Helios University Hospital Wuppertal, Germany; Department of Medicine, Faculty of Health, University of Witten/Herdecke, Witten, Germany., Hehr T; Department of Radiation Oncology, Marienhospital, Stuttgart, Germany., Eschmann SM; Department of Nuclear Medicine, Marienhospital, Stuttgart, Germany., Bultel YP; Department of Radiation Oncology, Klinikum Mutterhaus der Boromäerinnen, Trier, Germany., Hass P; Department of Radiation Oncology, University Hospital Magdeburg, Germany., Fleckenstein J; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Thieme AH; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Germany., Dieckmann K; Department of Radiotherapy, Vienna General Hospital, Medical University of Vienna, Austria., Miederer M; Department of Nuclear Medicine, University Hospital Mainz, Germany., Holl G; Department of Nuclear Medicine, Helios Kliniken Schwerin, Germany., Rischke HC; Department of Radiation Oncology, Medical Center, University of Freiburg, Germany; Faculty of Medicine, University of Freiburg, Germany; Department of Nuclear Medicine, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Adebahr S; Department of Radiation Oncology, Medical Center, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany., König J; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Hospital of Mainz, Germany., Binder H; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine, University of Freiburg, Germany., Nestle U; Department of Radiation Oncology, Medical Center, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine, University of Freiburg, Germany; Department of Nuclear Medicine, Medical Center, University of Freiburg, Germany.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Oct; Vol. 163, pp. 32-38. Date of Electronic Publication: 2021 Jul 24.
Zobrazit plný text záznamu
8
Akademický článek
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial.
Autor: Gkika E; Department of Radiation Oncology, Medical Center-University of Freiburg, Robert-Koch-Str. 3, 79106 Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany., Lenz S; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79106 Freiburg, Germany., Schimek-Jasch T; Department of Radiation Oncology, Medical Center-University of Freiburg, Robert-Koch-Str. 3, 79106 Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Neuenheimer Feld 280, 69120 Heidelberg, Germany., Waller CF; Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, Medical Center-University of Freiburg, 79106 Freiburg, Germany., Kremp S; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center and Faculty of Medicine, 66421 Homburg/Saar, Germany., Schaefer-Schuler A; Department of Nuclear Medicine, Saarland University Medical Center and Faculty of Medicine, 66421 Homburg/Saar, Germany., Mix M; Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Department of Nuclear Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany., Küsters A; Department of Radiation Oncology, Kliniken Maria Hilf, 41063 Mönchengladbach, Germany., Tosch M; Department of Nuclear Medicine, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany.; Department of Medicine, Faculty of Health, University of Witten/Herdecke, 58448 Witten, Germany., Hehr T; Department of Radiation Oncology, Marienhospital, 70199 Stuttgart, Germany., Eschmann SM; Department of Nuclear Medicine, Marienhospital, 70199 Stuttgart, Germany., Bultel YP; Department of Radiation Oncology, Klinikum Mutterhaus der Boromäerinnen, 54290 Trier, Germany., Hass P; Department of Radiation Oncology, University Hospital Magdeburg, 39120 Magdeburg, Germany., Fleckenstein J; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center and Faculty of Medicine, 66421 Homburg/Saar, Germany., Thieme AH; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany., Stockinger M; Department of Radiation Oncology, University Hospital Mainz, 55131 Mainz, Germany., Dieckmann K; Department of Radiotherapy, Vienna General Hospital, Medical University of Vienna, 1090 Vienna, Austria., Miederer M; Department of Nuclear Medicine, University Hospital Mainz, 55131 Mainz, Germany., Holl G; Department of Nuclear Medicine, Kliniken Schwerin, 19055 Schwerin, Germany., Rischke HC; Department of Radiation Oncology, Medical Center-University of Freiburg, Robert-Koch-Str. 3, 79106 Freiburg, Germany.; Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Department of Nuclear Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany., Adebahr S; Department of Radiation Oncology, Medical Center-University of Freiburg, Robert-Koch-Str. 3, 79106 Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Neuenheimer Feld 280, 69120 Heidelberg, Germany., König J; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Hospital of Mainz, 55131 Mainz, Germany., Binder H; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79106 Freiburg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center-University of Freiburg, Robert-Koch-Str. 3, 79106 Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany., Nestle U; Department of Radiation Oncology, Medical Center-University of Freiburg, Robert-Koch-Str. 3, 79106 Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Department of Radiation Oncology, Kliniken Maria Hilf, 41063 Mönchengladbach, Germany.
Publikováno v: Cancers [Cancers (Basel)] 2020 Nov 13; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 13.
Zobrazit plný text záznamu
9
Akademický článek
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
Autor: Wiedenmann N; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Büchert M; Department of Radiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rischke HC; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Nuclear Medicine, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Ruf J; Department of Nuclear Medicine, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bielak L; Department of Radiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Majerus L; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Rühle A; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bamberg F; Department of Radiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Baltas D; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hennig J; Department of Radiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Mix M; Department of Nuclear Medicine, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bock M; Department of Radiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Nicolay NH; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: nils.nicolay@uniklinik-freiburg.de.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Sep; Vol. 150, pp. 128-135. Date of Electronic Publication: 2020 Jun 13.
Zobrazit plný text záznamu
10
Akademický článek
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Autor: Nestle U; Department of Radiation Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany; Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany. Electronic address: ursula.nestle@mariahilf.de., Schimek-Jasch T; Department of Radiation Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany., Kremp S; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Schaefer-Schuler A; Department of Nuclear Medicine, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Mix M; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany., Küsters A; Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany., Tosch M; Department of Nuclear Medicine, Helios University Hospital Wuppertal, Wuppertal, Germany; Department of Medicine, Faculty of Health, University of Witten/Herdecke, Witten, Germany., Hehr T; Department of Radiation Oncology, Marienhospital Stuttgart, Stuttgart, Germany., Eschmann SM; Department of Nuclear Medicine, Marienhospital Stuttgart, Stuttgart, Germany., Bultel YP; Department of Radiation Oncology, Klinikum Mutterhaus der Boromäerinnen, Trier, Germany., Hass P; Department of Radiation Oncology, University Hospital Magdeburg, Magdeburg, Germany., Fleckenstein J; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center and Faculty of Medicine, Homburg/Saar, Germany., Thieme A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Department of Radiation Oncology, Berlin Institute of Health, Berlin, Germany., Stockinger M; Department of Radiation Oncology, University Hospital Mainz, Mainz, Germany., Dieckmann K; Department of Radiotherapy, Medical University of Vienna, Vienna General Hospital, Vienna, Austria., Miederer M; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany., Holl G; Department of Nuclear Medicine, Helios Kliniken Schwerin, Schwerin, Germany., Rischke HC; Department of Radiation Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany., Gkika E; Department of Radiation Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany., Adebahr S; Department of Radiation Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany., König J; Institute of Medical Biostatistics, Epidemiology and Informatics, University Hospital Mainz, Mainz, Germany., Grosu AL; Department of Radiation Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2020 Apr; Vol. 21 (4), pp. 581-592. Date of Electronic Publication: 2020 Mar 12.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje